Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M662Revenue $M14.2Net Margin (%)-730.7Z-Score8.5
Enterprise Value $M384EPS $-3.3Operating Margin %-731.8F-Score4
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-458.9Higher ROA y-yY
Price/Book2.210-y EBITDA Growth Rate %-9.1Quick Ratio10.4Cash flow > EarningsY
Price/Sales39.05-y EBITDA Growth Rate %25.2Current Ratio10.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-40.6Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-50.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M40.9ROI % (ttm)-300.9Gross Margin Increase y-yN

Gurus Latest Trades with SRPT

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SRPTGeorge Soros 2014-06-30 Add0.14%$22.18 - $38.91
($31.64)
$ 16.17-49%Add 2620%680,000
SRPTGeorge Soros 2014-03-31 Reduce-0.04%$17.91 - $30.29
($25.36)
$ 16.17-36%Reduce -89.27%25,000
SRPTGeorge Soros 2013-12-31 Reduce-0.22%$12.89 - $53.81
($29.58)
$ 16.17-45%Reduce -64.98%233,000
SRPTGeorge Soros 2013-09-30 Add0.12%$30.906 - $47.97
($38.37)
$ 16.17-58%Add 56.28%665,274
SRPTAndreas Halvorsen 2013-09-30 Sold Out -0.14%$30.906 - $47.97
($38.37)
$ 16.17-58%Sold Out0
SRPTAndreas Halvorsen 2013-03-31 Buy 0.15%$23.97 - $36.95
($28.83)
$ 16.17-44%New holding, 690731 sh.690,731
SRPTGeorge Soros 2013-03-31 Add0.08%$23.97 - $36.95
($28.83)
$ 16.17-44%Add 82.54%413,329
SRPTGeorge Soros 2012-12-31 Add0.05%$14.99 - $44.93
($26.74)
$ 16.17-40%Add 184.13%226,429
SRPTJean-Marie Eveillard 2012-03-31 Sold Out $4.5 - $9.6
($6.06)
$ 16.17167%Sold Out0
SRPTJean-Marie Eveillard 2011-12-31 Reduce$3.24 - $6.54
($5.04)
$ 16.17221%Reduce -83.33%50,000
SRPTJean-Marie Eveillard 2011-09-30 Add$6.3 - $9.9
($7.92)
$ 16.17104%Add 50%300,000
SRPTJean-Marie Eveillard 2011-06-30 Buy $8.1 - $11.22
($9.66)
$ 16.1767%New holding, 200000 sh.200,000
SRPTGeorge Soros 2006-03-31 Buy 0.08%$24.54 - $50.45
($41.39)
$ 16.17-61%New holding, 308100 sh.308,100
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SRPT is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
SRPT George Soros 2014-06-30680,0001.660.15+2620%
Premium Most recent portfolio changes are included for Premium Members only!


SRPT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CHASE ANTHONY RDirector 2013-11-14Buy10,000$13.9512.33view
Aphale JayantSVP Technical Operations 2013-11-12Sell15,933$12.5624.76view
BEHRENS M KATHLEENDirector 2013-09-16Buy6,500$37.04-57.69view
HODGMAN JOHNDirector 2013-09-03Sell5,556$34.97-55.19view
CHASE ANTHONY RDirector 2013-08-22Buy3,500$32.68-52.05view
Mahatme SandeshSenior Vice President, CFO 2013-08-20Buy5,000$31.1-49.61view
Price Ben GilDirector 2013-08-19Buy500$31.18-49.74view
CHASE ANTHONY RDirector 2013-06-14Buy10,000$38.5-59.3view
CHASE ANTHONY RDirector 2012-11-28Sell10,000$29.46-46.81view
CHASE ANTHONY RDirector 2012-11-14Sell10,000$25.7-39.03view

Press Releases about SRPT :

Quarterly/Annual Reports about SRPT:

News about SRPT:

Articles On GuruFocus.com
Ebola: Is The Cure Out There? Oct 14 2014 
Insiders Are Buying Fate Therapeutics Oct 09 2013 
comment on SRPT Mar 16 2013 
comment on SRPT Mar 16 2013 
comment on SRPT Feb 16 2013 

More From Our Partners
Fast Money Traders Discuss Merck, Garmin And Sarepta Therapeutics Oct 27 2014 - BENZINGA

More From Other Websites
Nasdaq stocks posting largest percentage decreases Oct 30 2014
Twitter and Amgen are big market movers Oct 28 2014
Sarepta Slumps as Eteplirsen NDA Submission Gets Delayed Oct 28 2014
Sarepta Therapeutics downgraded by Robert W. Baird Oct 28 2014
Sarepta Slumps: SRPT Plunges 32.5% in Session Oct 28 2014
[$$] Sarepta’s Muscular Dystrophy Drug Suffers Setback Oct 27 2014
Prosensa pops on Sarepta FDA delay Oct 27 2014
S&P 500 trades in a narrow range, up against key technical levels Oct 27 2014
Sarepta Gets Delayed And The Stock Gets Drilled Oct 27 2014
Petrobras Plunges In The Wake Of Brazilian Election Results Oct 27 2014
3 Stocks, 3 trades: MRK, GRMN & SRPT Oct 27 2014
Sarepta Needs FDA Expertise, Stat Oct 27 2014
Sarepta price target slashed by Piper Jaffray Oct 27 2014
Sarepta Therapeutics: Don't Catch This Falling Knife Oct 27 2014
Sarepta Faces Major Hurdle, and Not From Ebola Oct 27 2014
Sarepta Shares Falls on Duchenne Drug Approval Filing Delay Oct 27 2014
Sarepta tumbles on new delay for key drug Oct 27 2014
Sarepta tumbles on new delay for key drug Oct 27 2014
Stocks to Watch: Chiquita, Allergan, Merck Oct 27 2014
Biotech Stock Crashes After FDA Requires Additional Data For New Drug Application Oct 27 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK